HealthEquity Inc (STU:2HE)

€ 96 0 (0%) Market Cap: 8.43 Bil Enterprise Value: 9.22 Bil PE Ratio: 84.72 PB Ratio: 4.12 GF Score: 85/100

Q2 2025 Healthequity Inc Earnings Call Transcript
Sep 03, 2024

€71 (-0.70%)

Earnings
Q1 2025 Healthequity Inc Earnings Call Transcript
Jun 03, 2024

€75 (+1.35%)

Earnings
Q4 2024 Healthequity Inc Earnings Call Transcript
Mar 19, 2024

€76.5 (+0.66%)

Earnings
Healthequity Inc at JPMorgan Healthcare Conference Transcript
Jan 10, 2024
Q3 2024 Healthequity Inc Earnings Call Transcript
Dec 05, 2023

€63.5

Earnings
Q2 2024 Healthequity Inc Earnings Call Transcript
Sep 05, 2023

€62.5 (+1.63%)

Earnings
Healthequity Inc Annual Shareholders Meeting Transcript
Jun 22, 2023
Q1 2024 Healthequity Inc Earnings Call Transcript
Jun 05, 2023

€55.5 (+7.77%)

Earnings
Q4 2023 Healthequity Inc Earnings Call Transcript
Mar 21, 2023

€52.5 (+0.96%)

Earnings
Healthequity Inc at JPMorgan Healthcare Conference Transcript
Jan 11, 2023
Q3 2023 Healthequity Inc Earnings Call Transcript
Dec 06, 2022

€64 (+4.07%)

Earnings
Q2 2023 Healthequity Inc Earnings Call Transcript
Sep 06, 2022

€65 (+0.78%)

Earnings
Q1 2023 Healthequity Inc Earnings Call Transcript
Jun 06, 2022

€59.5

Earnings
Q4 2022 Healthequity Inc Earnings Call Transcript
Mar 22, 2022

€52.22 (+1.79%)

Earnings
Full Year 2022 Healthequity Inc Corporate Sales Call Transcript
Feb 22, 2022
Healthequity Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Jan 12, 2022
Q3 2022 Healthequity Inc Earnings Call Transcript
Dec 06, 2021

€49.59 (+2.71%)

Earnings
Healthequity Inc at Cantor Fitzgerald Global Healthcare Conference (Virtual) Transcript
Sep 30, 2021
Q2 2022 Healthequity Inc Earnings Call Transcript
Sep 08, 2021

€53.44 (-1.73%)

Earnings
Healthequity Inc Annual Shareholders Meeting Transcript
Jun 24, 2021
Q1 2022 Healthequity Inc Earnings Call Transcript
Jun 07, 2021

€66.42 (-0.57%)

Earnings
Q4 2021 Healthequity Inc Earnings Call Transcript
Mar 15, 2021

€67 (+3.88%)

Earnings
Full Year 2020 Healthequity Inc Corporate Sales Call Transcript
Feb 08, 2021
Q3 2021 Healthequity Inc Earnings Call Transcript
Dec 07, 2020

€57 (-2.56%)

Earnings
Q2 2021 Healthequity Inc Earnings Call Transcript
Sep 08, 2020

€50.5 (+3.06%)

Earnings
Q1 2021 HealthEquity Inc Earnings Call Transcript
Jun 02, 2020

€55.5 (+0.91%)

Earnings
Q4 2019 HealthEquity Inc Earnings Call Transcript
Mar 16, 2020

€43.6

Earnings
Full Year 2019 HealthEquity Inc Corporate Sales Call Transcript
Feb 18, 2020
HealthEquity Inc at JPMorgan Healthcare Conference Transcript
Jan 15, 2020
Q3 2019 HealthEquity Inc Earnings Call Transcript
Dec 03, 2019

€55

Earnings
Q2 2020 HealthEquity Inc Earnings Call Transcript
Sep 03, 2019

€54.09 (+0.28%)

Earnings
HealthEquity Inc to Acquire WageWorks Inc - M&A Call Transcript
Jun 27, 2019
HealthEquity Inc Corporate Analyst Meeting Transcript
Jun 19, 2019
Q1 2019 HealthEquity Inc Earnings Call Transcript
Jun 04, 2019

€55.91 (-3.25%)

Earnings
Q4 2018 HealthEquity Inc Earnings Call Transcript
Mar 18, 2019

Earnings

HealthEquity Inc at JPMorgan Healthcare Conference Transcript

Jan 15, 2020 / 05:30PM GMT

Release Date Price: €64.5

Transcript

Anne Elizabeth Samuel

JP Morgan Chase & Co, Research Division - Analyst

Good morning, everyone, and welcome to the HealthEquity presentation at the JPMorgan Healthcare Conference. My name is Annie Samuel, and I cover health care IT here at JPMorgan. We're thrilled to have HealthEquity with us this morning. We've got CEO, Jon Kessler. We'll be taking questions in the Borgia Room afterwards, and we'll have you joined with CFO, Darcy Mott. So let me turn it over to Jon.

Jon Kessler

HealthEquity, Inc. - President, CEO & Director

Hi, everybody. Good morning. Thanks. I appreciate that. First of all, I want to say this Crystal Geyser water, this is excellent. I don't know if you guys -- I don't usually like this stuff. It's fantastic, in all seriousness.

So listen, we have this presentation, but you'll be relieved to know I'm not going to go through it. Instead, I'd like to talk for a couple minutes and maybe I'll be even able to give you a few extra minutes of your time back. I'd like to talk about where we are on the points that I think you as

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.